Jefferies Group LLC Sorrento Therapeutics, Inc. Transaction History

Jefferies Group LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 13, 2020	BUY	$6.17 - $18.82 $27,913 - $85,141	4,524 New	4,524 $50,000
Q1 2019 May 15, 2019	SELL	$1.86 - $5.94 $97,661 - $311,885	-52,506 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$2.01 - $4.24 $32,976 - $69,561	16,406 Added 45.45%	52,506 $126,000
Q3 2018 Nov 14, 2018	BUY	$4.22 - $7.5 $152,342 - $270,750	36,100 New	36,100 $159,000
Q2 2018 Aug 14, 2018	SELL	$4.75 - $8.0 $65,550 - $110,400	-13,800 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$4.5 - $9.95 $62,100 - $137,310	13,800 New	13,800 $71,000

5.47M

Ticker SRNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 449,952,000
Market Cap $148M
Description
Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

Stay updated on Jefferies Group LLC with notifications on news.